Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

5 Nov 2018 07:00

RNS Number : 2648G
Cenkos Securities PLC
05 November 2018
 

 

 

 5 November 2018

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

The Board is pleased to announce that, subject to FCA approval, Jim Durkin is to be appointed as an Executive Director and to the position of Chief Executive Officer once regulatory approval has been received. In the interim period Anthony Hotson remains as the Company's Chief Executive Officer.

Jim, a founding shareholder of the Company, was formerly Cenkos' Chief Executive Officer in the period December 2011 to July 2017. Jim resigned as Chief Executive Officer in July 2017. Jim Durkin has over 30 years' experience in the UK securities industry. During his career he has had substantial experience originating and executing corporate finance transactions across a range of industries including insurance, property, financials and utilities.

The Board today also announces that Gerry Aherne, the Chairman of the Company has informed the Board that he will step down and retire from the Company with immediate effect.

The Board would like to thank Gerry for his commitment and contribution to the Company as Chairman over the past six years and wish him well in the future.

The Board will commence the search for a new Chairman. Jeff Hewitt a Non-executive Director has been appointed as the acting Chairman in the interim period.

Jeff Hewitt the acting Chairman commented that:

"We welcome Jim back to the Company and have every confidence in Jim in leading the Company going forward. Jim is well placed to undertake the role having previously been on the Board and has been actively involved in the successful management of the Company."

AIM Rules disclosure under Schedule 2(g) of the AIM Rules

James John Durkin (known as Jim Durkin) holds 4,985,831 ordinary shares of 1p each in the Company representing 9.01% of the issued share capital of the Company.

In addition to his appointment to the Board, James John Durkin, aged 58, holds or has held the following directorships or partnerships in the past five years:

Current directorships:

JDPL Limited

 

Previous directorships:

Cenkos Securities plc

Cenkos Nominee UK Limited resigned

Cenkos Fund Management Limited

JDPL 2 Limited

 

There is no further information that is required to be disclosed with regards to the appointment of Jim Durkin pursuant to Schedule 2 paragraph (g) of the AIM Rules.

 

For further information, please contact: 

 

Cenkos Securities plc

Jeff Hewitt, Acting Non- Executive Chairman

 

Tel: 0207 397 8900

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser

 

Tel: 0203 368 3552

Whitman Howard Limited

Nick Lovering, Broker

 

Tel: 0207 659 1224

Buchanan Communications

David Rydell, PR Adviser

 

Tel: 0207 466 5066

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABJBBTMBBMMJP
Date   Source Headline
15th Apr 20199:48 amRNSForm 8.5 (EPT/NON-RI)
12th Apr 201911:05 amRNSForm 8.5 (EPT/NON-RI)
11th Apr 20199:57 amRNSForm 8.5 (EPT/NON-RI)
10th Apr 201912:36 pmRNSPDMR Shareholding
10th Apr 201912:35 pmRNSEBT Share Transfer
8th Apr 20195:05 pmRNSEBT Share Purchase
5th Apr 20192:30 pmRNSEBT Share Purchase
5th Apr 20191:57 pmRNSAnnual Report and Annual General Meeting Notice
2nd Apr 201912:27 pmRNSEBT Share Purchase
1st Apr 201912:08 pmRNSEBT Share Purchase
1st Apr 201910:16 amRNSDirectorate Changes
26th Mar 201912:33 pmRNSDirector/PDMR Shareholding
26th Mar 20197:00 amRNSAnnual Results for the year ended 31 December 2018
13th Mar 201910:54 amRNSEBT Share Purchase
11th Mar 20197:00 amRNSDirectorate Change
19th Feb 20191:05 pmRNSEBT Share Purchase
7th Feb 201910:19 amRNSEBT Share Purchase
29th Jan 201910:08 amRNSEBT Share Purchase
28th Jan 201911:11 amRNSEBT Share Purchase
25th Jan 201910:44 amRNSEBT Share Purchase
23rd Jan 20194:14 pmRNSEBT Share Purchase Plan
19th Dec 20183:50 pmRNSTrading Update
12th Dec 20183:56 pmRNSEBT Share Purchase
12th Dec 20187:45 amRNSAcquisition of Business
12th Dec 20187:00 amRNSDirectorate Changes
28th Nov 20184:09 pmRNSEBT Share Purchase
28th Nov 201810:00 amRNSPDMR Shareholding
7th Nov 201810:35 amRNSEBT Share Purchase
6th Nov 20185:10 pmRNSAward of shares under SIP and Directors' Dealings
6th Nov 20181:33 pmRNSEBT Share Purchase
5th Nov 20187:00 amRNSBoard Changes
31st Oct 20184:29 pmRNSBoard Change
16th Oct 20185:14 pmRNSBlock listing Interim Review
9th Oct 20187:00 amRNSBoard Change
3rd Oct 201810:02 amRNSEBT Share Purchase
18th Sep 20187:00 amRNSInterim Results for six months ended 30 June 2018
10th Sep 201812:00 pmRNSEBT Share Purchase
7th Sep 201810:19 amRNSEBT Share Purchase
16th Aug 201812:19 pmRNSEBT Share Purchase
6th Aug 201812:02 pmRNSEBT Share Purchase
1st Aug 20187:00 amRNSAcquisition of business
24th Jul 201811:06 amRNSSecond Price Monitoring Extn
24th Jul 201811:00 amRNSPrice Monitoring Extension
24th Jul 20187:00 amRNSTrading Update
23rd Jul 20185:33 pmRNSEBT Share Purchase
20th Jul 20187:00 amRNSChange of Adviser
3rd Jul 20189:02 amRNSForm 8.5 (EPT/NON-RI)
2nd Jul 20189:47 amRNSForm 8.5 (EPT/NON-RI)
29th Jun 201810:31 amRNSForm 8.5 (EPT/NON-RI)
25th Jun 201811:50 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.